| 239 | 34 | 110 |
| 下载次数 | 被引频次 | 阅读次数 |
目的检测高危型人乳头状瘤病毒(HR-HPV)的感染状态与宫颈病变的发生及发展的相关性。方法对我院门诊2 876例妇女采用液基薄层细胞检测(TCT)、第二代杂交捕获法技术(HC2)-HPV-DNA检测及HPV分型检测,以TCT细胞学正常及高危型HPV阳性的妇女295人为目标人群,随访重复TCT细胞学和HPV基因分型,并对TCT细胞学异常的妇女进行阴道镜下宫颈组织活检。分析不同HPV感染型别、感染状态(持续性感染、间断性感染及感染清除)的TCT异常和宫颈病理异常的发生情况。结果目标群体随访1年,持续性HPV感染的女性与HPV感染清除或间断性感染的妇女相比宫颈病变的发生率无显著差异(P>0.05);目标群体随访2年,持续性HPV感染女性比HPV感染清除或间断性感染妇女有更高的宫颈病变发生率(P<0.01)。多重HPV感染并不比单一型别感染有更高的宫颈病变发生率(P>0.05)。高危型HPV16和HPV18持续感染发生率高,且宫颈病变的发生率增加(P<0.05)。结论持续性HPV感染2年以上,尤其HPV16及HPV18的持续性感染,发生宫颈病变的风险明显增加。高危HPV型别及感染状态的甄别更有临床指导意义。
Abstract：Objective:To explore the correlation of high-risk human papillomavirus(HPV)infection status and genotyping with occurrence of cervical lesions.Methods:A total of outpatient 2 876 women were detected by Thinprep cytology test(TCT),HC2-HPV-DNA and HPV genotyping in Beijing Jishuitan Hospital.Among them,295 women with normal TCT and positive high-risk HPV were selected as target group.Repeated TCT and HPV-genotyping were done during 1-2years of follow-up.Women with TCT cytological abnormality were performed with colposcopic biopsy and pathological diagnosis.Infection of high-risk HPV was classified to following categories:clearance of HPV infection,intermittent and persistent HPV infection,single or multiple HPV infection.Results:The morbidity of cervical lesions in the women with persistent HPV infection for more than two years was significantly higher than that in the women with HPV infection clearance or intermittent infection(P<0.01).The multiple HPV infection was less likely to increase the risk of cervical lesions compared with single HPV infection.Persistent infection of HR-HPV 16 or 18increased the occurrence of cervical lesions(P<0.05).Conclusions:Persistent HR-HPV infection especially HR-HPV-16 and 18for more than two years increases the risk of cervical lesions.HPV genotyping and the duration of infection possess clinical significance for occurrence of cervical lesions.
[1]Schiffman M,Castle PE.Human papillomavirus:epidemiology and public health[J].Arch Pathol Lab Med,2003,127:930-934.
[2]Steben M,Duarte-Franco E.Human papillomavirus infection:epidemiology and pathophysiology[J].Gynecol Oncol,2007,107(2Suppl 1):S2-5.
[3]Hildesheim A,Schiffman MH,Tsukui T,et al.Immune activation in cervical neoplasia:cross-sectional association between plasma soluble interleukin 2receptor levels and disease[J].Cancer Epidemiol Biomarkers Prev,1997,6:807-813.
[4]Saito M,Okubo M,Hirata R,et al.Association of human leukocyte antigen and T cell message with human papillomavirus 16-positive cervical neoplasia in Japanese women[J].Int J Gynecol Cancer,2007,17:1314-1321.
[5]Cuschieri KS,Cubie HA,Whitley MW,et al.Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study[J].J Clin Pathol,2005,58:946-950.
[6]Carter JR,Ding Z,Rose BR.HPV infection and cervical disease:a review[J].Aust N Z J Obstet Gynaecol,2011,51:103-108.
[7]郎景和.迎接子宫颈癌的全球挑战与机遇[J].中华妇产科杂志,2002,37:153.
[8]王又又,向群英,佘茜,等.宫颈癌高发区妇女HPV感染及影响因素分析[J].中国公共卫生,2011,27:259-261.
[9]杨丽.宫颈HPV检测在宫颈癌前病变筛选中的临床意义[J].中国临床研究,2011,24:129-130.
[10]Cronje HS.Screening for cervical cancer in developing countries[J].Int J Gynaecol Obstet,2004,84:101-108.
[11]Pimple S,Muwonge R,Amin G,et al.Cytology versus HPV testing for the detection of high-grade cervical lesions in womenfound positive on visual inspection in Mumbai India[J].Int J Gynaecol Obstet,2010,108:236-239.
[12]Srbye SW,Fismen S,Gutteberg TJ,et al.HPV test in the prevention of cervix cancer[J].Tidsskr Nor Laegeforen[Norw],2012,132:396-397.
[13]Ivanov S.The role of the cytological screening,HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix[J].Akush Ginekol(Sofiia)[Bulg],2007,46:45-49.
[14]Franco EL.Persistent HPV infection and cervical cancer risk:is the scientific rationale for changing the screening paradigm enough?[J].J Natl J Natl Cancer Inst,2010,102:1451-1453.
[15]PetjT,Pedersen C,Poder A,et al.Long-term persistence of systemic and mucosal immune response to HPV-16/18AS04-adjuvanted vaccine in preteen/adolescent girls and young women[J].Int J Cancer,2011,129:2147-2157.
[16]Kreimer AR,Schiffman M,Herrero R,et al.Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment[J].Int J Cancer,2012,131:211-218.
[17]Feller L,Wood NH,Khammissa RA,et al.HPV modulation of host immune responses[J].SADJ,2010,65:266-268.
[18]Terlou A,van Seters M,Kleinjan A,et al.Imiquimod-induced clearance of HPV is associated with normalization of immune cell counts in usual type vulvar intraepithelial neoplasia[J].Int J Cancer,2010,127:2831-2840.
基本信息:
中图分类号:R737.33
引用信息:
[1]王雪卿,孙丽芳,梁向华,等.高危型人乳头状瘤病毒的感染状态及分型与宫颈病变发生的相关性研究[J].生殖医学杂志,2014,23(08):633-638.
2014-08-15
2014-08-15